ARID5B and acute lymphoblastic leukemia: The suppression of ARID5B inhibited ALL cell proliferation, caused partial cell-cycle arrest and led to resistance specific to both antimetabolite drugs 6-mercaptopurine and methotrexate in ALL cells with ARID5B downregulation (Zhao et al., 2022).